Schonfeld Strategic Advisors LLC Genmab A/S Transaction History

Schonfeld Strategic Advisors LLC

$13.8 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$35.27 - $42.24 $8 Million - $9.58 Million	226,802 New	226,802 $8 Million
Q3 2022 Nov 14, 2022	BUY	$31.52 - $373.61 $1.14 Million - $13.5 Million	36,090 Added 17.13%	246,828 $7.93 Million
Q2 2022 Aug 15, 2022	BUY	$26.83 - $38.57 $3.16 Million - $4.54 Million	117,628 Added 126.33%	210,738 $6.85 Million
Q1 2022 May 16, 2022	BUY	$30.95 - $39.68 $84,772 - $108,683	2,739 Added 3.03%	93,110 $3.37 Million
Q4 2021 Feb 14, 2022	SELL	$35.87 - $47.12 $1.47 Million - $1.94 Million	-41,098 Reduced 31.26%	90,371 $3.57 Million
Q3 2021 Nov 16, 2021	BUY	$41.55 - $48.72 $2.12 Million - $2.49 Million	51,019 Added 63.42%	131,469 $5.75 Million
Q2 2021 Nov 16, 2021	SELL	$32.88 - $44.57 $65,760 - $89,140	-2,000 Reduced 2.43%	80,450 $3.28 Million
Q2 2021 Aug 16, 2021	SELL	$32.88 - $44.57 $2.24 Million - $3.04 Million	-68,183 Reduced 45.26%	82,450 $3.37 Million
Q1 2021 May 17, 2021	BUY	$30.92 - $44.4 $1.97 Million - $2.84 Million	63,874 Added 73.62%	150,633 $4.95 Million
Q4 2020 Feb 16, 2021	SELL	$33.66 - $40.76 $33,962 - $41,126	-1,009 Reduced 1.15%	86,759 $3.53 Million
Q3 2020 Nov 16, 2020	BUY	$33.07 - $38.68 $1.53 Million - $1.79 Million	46,213 Added 111.21%	87,768 $3.21 Million
Q2 2020 Aug 14, 2020	BUY	$20.05 - $33.89 $125,252 - $211,710	6,247 Added 17.69%	41,555 $1.41 Million
Q1 2020 May 15, 2020	SELL	$17.15 - $25.22 $1.15 Million - $1.69 Million	-67,092 Reduced 65.52%	35,308 $748,000
Q4 2019 Feb 14, 2020	SELL	$18.88 - $24.14 $3.05 Million - $3.9 Million	-161,645 Reduced 61.22%	102,400 $2.29 Million
Q3 2019 Nov 14, 2019	BUY	$18.0 - $21.38 $4.75 Million - $5.65 Million	264,045 New	264,045 $5.35 Million

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

Alliancebernstein L.P. New York, NY

15.1M
Shares

$312 Million
0.13% of portfolio
Black Rock Inc. New York, NY

5.08M
Shares

$105 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

4.42M
Shares

$91 Million
0.02% of portfolio
Harding Loevner LP Bridgewater, NJ

3.07M
Shares

$63.1 Million
0.44% of portfolio
Wellington Management Group LLP Boston, MA

2.31M
Shares

$47.5 Million
0.01% of portfolio

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account